Purpose The purpose of this study was to evaluate the clinical and radiological outcome following compression plate fixation in combination with autologous bone grafting, with and without additional application of recombinant human bone morphogenetic protein (rhBMP) for treatment of aseptic clavicle non-union. Methods Between April 2004 and April 2015, 82 patients were treated for clavicle fracture and had developed aseptic clavicle non-union. Seventy-three out of 82 patients were available for follow-up at least one year after revision surgery; among them, 27 women and 46 men, with a median age of 49 (range, 19-86) years. Forty-five patients received compression plate osteosynthesis with autologous bone grafting, and 28 patients obtained compression plate fixation with autologous bone grafting and additional application of rhBMP-2 (3/28 patients) or rhBMP-7 (25/28 patients). Results Seventy out of 73 non-unions (96 %) healed within 12 months after revision surgery. Functional outcome according to the DASH Outcome Measure (with rhBMP, 33.16 ± 1.17 points; without rhBMP, 30.58 ± 2.12 points [mean ± SEM]; p = 0.81), non-union healing (p = 0.86), time interval between revision surgery and bone healing (p = 0.37), as well as post-operative complications, did not demonstrate relevant differences between the treatment groups and were not agedependent. Discussion Functional and radiological results demonstrate that successful healing of aseptic clavicle non-union is dependent on radical resection of non-union tissue, restoration of length of the shoulder girdle and application of stable locking-plate osteosynthesis in combination with autologous bone grafting, but not dependent on application of additional rhBMP.
Introduction
About 5 % of all fractures in adults involve the clavicle, and most of them are located in the middle third of the shaft [1, 2] . Historically, conservative treatment was recommended for clavicle fractures. However, the majority of these fractures are characterised by displacement of fracture fragments. Recent literature reports an increased risk of symptomatic non-union for comminuted clavicle fractures following conservative as well as surgical treatment including plate osteosynthesis or intramedullary fixation using pins, screws, wires or nails [2] . Approximately one-third of the complications may be avoided by choosing the adequate surgical treatment option [3] . Reliable data are not available, but it is common consensus that symptomatic non-union of clavicle fractures in adults characterised by local tenderness at the nonunion site and pain with shoulder motion is relatively rare [4] . Significant risk factors including drug abuse, diabetes and previous surgery of the shoulder have been identified to contribute to the development of non-union or fixation failure [5] . Non-union of clavicle fractures remains a devastating problem in terms of the anatomical configuration and function of the shoulder girdle, and there is still no Bgold standard^for operative treatment. Therefore, surgical treatment is complex, technically challenging and may not be cost-effective [6] . Earlier studies demonstrated that treatment of clavicle nonunion using classic surgical techniques of straight or precontoured compression plate osteosynthesis and autologous bone grafting resulted in relatively high clinical and radiological union rates [7] . In symptomatic clavicle non-union or malunion, restoration of the anatomic bone configuration is a mandatory precondition to induce solid osseous healing. Anatomical restoration of length is achieved by performing an osteotomy of the malunited site, followed by application of autologous bone graft and rigid compression plate osteosynthesis. In principal, interposition of autologous bone grafting is a successful tool for the reconstruction of segmental bone loss [8] . Biological augmentation with autologous nonvascularised corticocancellous, cancellous or vascularised grafts, is an important option for successful treatment of non-union, despite increased donor site morbidity [9, 10] . In this context, only a few case reports have assessed the additional application of recombinant human bone morphogenetic protein (rhBMP) in the upper extremity [11, 12] .
In this cohort study, the surgical revision concept of open compression plating and autologous bone grafting, with and without additional use of rhBMP, for the treatment of aseptic clavicle non-union was evaluated to determine if osseous healing of aseptic clavicle non-union occurred more frequently, time to bone healing was shorter, and clinical and radiological outcome was better following additional application of rhBMP compared with no rhBMP application.
Patients and methods
In an 11-year period between April 2004 and April 2015, a retrospective cohort study was performed in a level-1 trauma centre.
Inclusion criteria for the study were as follows: Fractures were classified according to the Allman classification (Table 1 ) [1] . Fracture healing was defined using the following clinical and radiological outcome parameters: ability to perform weight-bearing without pain, stability at nonunion site, the formation of callus at all four cortices (Heckman's criteria of fracture healing) and the elimination of fracture lines [14] . If fracture healing was not clearly visible on X-ray imaging, a computed-tomography scan was performed to detect radiological non-union. The modern definition of a non-union used in this study is the point of time when normal bone healing processes ceased to the extent that union cannot occur without any additional operative intervention [15] .
Standard surgical technique: locking compression plate and autologous bone graft
In the surgical procedure, the previous surgical approach was used and optionally extended to explore the nonunion site. Implants were removed, and devitalised tissue was extensively debrided until normal viable osseous and soft tissue margins were obtained. Specimens were sent for cultures after removing the initial hardware. Three different diagnostic methods (culture of tissue samples, culture of intraoperative swabs, histopathology of tissue samples) were compared. Biological augmentation involved radical resection of fibrous nonunion tissue and application of autologous bone graft. The material was predominately harvested from the iliac crest, or locally from hypertrophic bone formation at the non-union site. For correct restoration of clavicle length, interposition of autologous bone graft was required. For stabilisation of both the non-union and the autologous bone graft interposition, rigid compression plate osteosynthesis using a long, bridging locking compression plate (LCP) was performed irrespective of the location of clavicle fracture (medial, middle or lateral third).
Additional rhBMP application
Additional application of rhBMPs in this study was conducted using rhBMP-7 (OP-1®; Stryker Biotech, Kalamazoo, MI, USA) from 2004 until April 2013, or rhBMP-2 (InductOs®; Medtronic Biopharma, Heerlen, The Netherlands) starting in May 2013. One complete unit of rhBMP-2 or rhBMP-7 was applied to the non-union area according to manufacturer's instructions in each case. The decision to utilise rhBMP was dependent on the intraoperative assessment and the discretion of the treating orthopaedic trauma surgeon.
Follow-up
After revision surgery, the identical rehabilitation protocol was conducted with all patients [16] . Follow-up studies were performed at regular intervals, including one week, six weeks, three months and six months, as well as at the most recent office visit to the Department of Orthopaedic Trauma. Followup assessment included thorough physical examination, functional evaluation, and diagnostic radiological studies. The influence of the treatment outcome on patients' mental and physical health status was assessed using the DASH (Disabilities of the Arm, Shoulder and Hand) Outcome Measure [17] . Outcome measures are presented as median values and quartiles.
Statistical analysis
Significance between groups was statistically assessed based on Mann-Whitney test. Statistical analysis was performed using IBM SPSS® Statistics for Windows 19.0 (IBM, Armonk, New York, USA). A result was considered to be statistically significant with p value <0.05.
Compliance with ethical standards
All procedures performed in this study involving human participants were in accordance with the bioethical standards of the institutional and national research committee (ID, 2016-019) and with the 1964 Helsinki declaration and its later amendments. Written informed consent was obtained from all individuals participating in the study. Patients were explicitly informed about the Boff label^use of rhBMP-2 and rhBMP-7 [18] . 
Results
An overview of all patients included in this study is displayed in Table 1 . Eighty-two patients had been treated with clavicle fracture and had developed aseptic clavicle non-union (Fig. 1) . Seventy-three out of 82 patients were available for final follow-up at least one year after revision surgery, among them 27 women and 46 men patients with a median age of 49 (range, 19-86) years. Fifty-three out of 73 patients were referred from an outside hospital, whereas 20 patients were initially treated at our institution. Fourteen patients suffered the clavicle fracture as part of major trauma. Twenty-one patients suffered a car accident, six patients a motor bike accident, 13 patients a bicycle accident, one patient a ski accident, one patient a fall from horseback and another patient a fall from a ladder. Simple falls occurred in 26 patients and a blunt impact in four patients. According to the Allman classification [1] , 57 fractures were located in the middle third, ten were in the lateral third and six were in the medial third. One patient had an associated brachial plexus lesion. The primary treatment for clavicle fracture consisted of conservative treatment in 33 patients, whereas in 40 patients primary operative fracture treatment had been performed. For surgical fracture treatment, 27 one-third tubular plates, six ESIN nails, one ECMES nail (Fig. 5) , one Prevot nail, one LCP, two tension band fixation and two Hook plates were used. Hypotrophic and atrophic non-union occurred in 54 and 17 patients, respectively. In two patients, hypertrophic non-union was found.
Operative non-union therapy was performed by two consultants and their teams after a median time period of 15 months following the primary fracture treatment. Forty-five patients received LCP osteosynthesis with autologous bone grafting (42/45 cancellous bone grafting, Fig. 2 ; 5/45 iliac crest bone grafting, Fig. 3 ) alone and 28 patients received LCP fixation with autologous bone grafting and additional application of rhBMP-2 (3/28 patients) or rhBMP-7 (25/28 patients).
With our surgical concept, osseous healing of the clavicle non-union (Fig. 4) One out of these non-unions healed in the further course, Fig. 1 A 67-year-old woman after a simple fall on the left clavicle, resulting in a fracture of the middle third. Development of aseptic non-union four months after conservative treatment at an outside institution Fig. 2 A 47-year-old woman: insertion of an autologous cancellous bone graft from iliac crest and fixation with a rigid LCP whereas the remaining three non-unions persisted. In two patients treated with additional use of rhBMP-7, impaired wound healing and inflammation, but no infection, occurred during the osseous consolidation process after revision surgery without any need for further surgical intervention.
Discussion
Revision rates after operative treatment of clavicle fractures have been reported to reach up to 25 % [19] . Several of these surgical interventions are caused by development of delayed union or non-union at the fracture site. Modern treatment concepts include radical excision of the non-union site, surgical debridement, open reduction and internal fixation using a rigid LCP and application of autologous bone graft, with or without additional administration of rhBMP [20] . Although an increased risk for short-term complications is related to the surgical treatment of clavicle non-union compared with acute fracture treatment [21] , autologous bone graft is commonly considered to be the safest and most effective grafting procedure, since it contains a patient's own bone growing cells to enhance osteogenesis and proteins to enhance osteoinduction, while providing a matrix for bone ingrowth (osteoconduction) [8] . In addition, application of autologous bone graft is performed with the purpose of filling bone defects, and precisely restoring the length and anatomical alignment of the clavicle.
It is critical to achieve high osteosynthetic stability. Thus, bridging plate fixation using an LCP is recommended, and it is advised to insert three or four screws in each fragment, preferably with bicortical screw fixation. Stabilisation using a long, bridging plate requires an extended surgical approach and exposition of the non-union site. Radical resection of interfragmentary fibrous non-union tissue is mandatory. For improvement of local non-union biology, it may also be indicated to perform decortication, resection of avital sclerotic bone and to open a sealed intramedullary canal by using a small-diameter drill.
For promoting bone healing, additional adjuvant treatment concepts using rhBMP have been proposed. Although it remains to be determined if the local environment around an atrophic non-union site is characterised by a deficit of rhBMP or rhBMP receptors, it has been suggested that topical, or local application of rhBMP may be beneficial in accelerating bone healing. Several techniques of rhBMP application Fig. 3 In the 67-year-old female patient presented in Fig. 1 , an autologous tricortical bone graft from the iliac crest was used in combination with rhBMP-7 application and rigid LCP fixation Fig. 4 The 47-year-old female patient presented in Fig. 2 : elective metal removal following non-union healing 12 months after revision surgery have been utilised including local injection, direct and open application into the non-union site, or insertion of rhBMPcoated implants [22] . RhBMPs promote signalling, chemotaxis, mitosis and differentiation of progenitor cells in the biological process of osteogenesis, and have been shown to accelerate bone healing in both settings of fracture and non-union healing [23] . To our knowledge, this study represents the only trial of aseptic clavicle non-union treated with additional application of both, rhBMP-2 and rhBMP-7, and with at least one year of functional and radiological follow-up. Clinical and radiological results of this study demonstrated complete bone healing in 27 out of 28 patients (96 %) following additional application of rhBMP-2 or rhBMP-7. Risk of impaired wound healing and inflammation, but not infection, following application of rhBMP was found in our study. The phenomenon of transient, local soft-tissue inflammation is a typical adverse effect of rhBMP application. In general, no surgical intervention is required.
A recent study conducted by Morison et al. [24] evaluated the surgical treatment of aseptic long-bone non-union in the upper extremity, and concluded that the application of rhBMP-7 was an effective treatment method with a healing rate of 92 % (22 out of 24 patients), which was a healing rate comparable to the results of our study. In contrast to earlier observations [4, 22] , the clinical results of this trial demonstrated good or excellent overall functional results in both treatment groups. Furthermore, despite positive effects on non-union healing in long bones [4, 22] and improved quality of life with the use of rhBMP-7 [15] , our results demonstrated no significantly increased non-union healing rate or improvement of functional results after additional application of rhBMP. Some studies have also emphasised economic benefits for rhBMP application in non-union treatment by reducing overall treatment time and, thus, treatment costs [22, 25, 26] . Even under economic aspects, the results of our study are not conclusive in order to recommend a general use of rhBMP for the revision treatment of aseptic clavicle non-union, since the rate and time to healing was not significantly different between the two treatment groups. In addition, no relevant correlation between the anatomical localisation of the non-union site at the clavicle, and treatment was found in our trial.
The limitations of this study include the variety of age of patients, initial fracture treatment, and time interval between the fracture and the treatment of the non-union as well as the sequential nature of the two cohort groups. However, the most important outcome assessment of this study was to evaluate the success rate of osseous union using the operative revision technique as described above. The decision to utilise rhBMP was dependent on the intra-operative assessment and the discretion of the treating orthopaedic surgeon, and was not subject to randomised or blinded protocol. Although it is a retrospective investigation, the strengths of the study include the large number of patients managed according to clear inclusion and exclusion criteria, with a consistent standard-treatment protocol in the same hospital by the same group of surgeons with extensive surgical experience in the treatment of clavicle non-union.
In conclusion, functional and radiological results of this study demonstrate that successful bone healing of aseptic clavicle non-union is dependent on a precise surgical technique including radical resection of non-union tissue, restoration of length by interposition of autologous bone graft to prevent shortening of the shoulder girdle and stable locking compression plate fixation, but is independent of the application of additional rhBMP.
